We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

12 Jul 2016 13:45

RNS Number : 9677D
Frontier Resources International
12 July 2016
 

Frontier Resources International Plc

("Frontier" or the "Company")

12 July 2016

Issue of Equity

The Board of Frontier (AIM Ticker: FRI) announces that the Company has today allotted and issued 40,143,351 new Ordinary Shares.

This comprises the following:

1. Exercise of Warrants

As at close of business on 7 July 2016, valid exercise notices were received from holders of 40,139,630 warrants which were issued in February 2016 ("Warrants"). The exercise price is 0.03p per ordinary share of 0.01p ("Ordinary Share") and the gross proceeds of exercise amounted in aggregate to £12,041.89, which provides additional working capital for the Company.

Included in the figures above are the following exercises of warrants by Directors which are shown in the table at the bottom of this announcement.

 

The next, and final, exercise date for the outstanding warrants is 7 October 2016. If the proposed share consolidation (in which one New Ordinary Share of 2.5p will replace every 250 Ordinary Shares) ("Share Consolidation") is approved at the General Meeting scheduled for 25 July 2016, holders of remaining Warrants will have to divide the number of their Warrants by 250 to calculate the number of New Ordinary Shares the subject of the Warrants, and the exercise price of such Warrants will be 7.5p per New Ordinary Share.

2. Issue of new Ordinary Shares to purchase the outstanding deferred shares

As also announced on 7 July, the Company intends to tidy up its capital structure by acquiring, as it is entitled, all the outstanding deferred shares (which are effectively worthless) in the Company for consideration of £1. Once these deferred shares are cancelled, the Ordinary Shares will constitute the only class of share capital in the Company.

In order to achieve this, the Company has therefore allotted 3,721 Ordinary Shares at an issue price of 0.03p per Ordinary Share to Barbara Spurrier to create the share premium necessary.

 

The new Ordinary Shares will, on issue, rank pari passu with the existing Ordinary Shares in issue, other than in respect of the following : they will not be eligible for participation in the Open Offer announced on 7 July. Application will be made for the new Ordinary Shares to be admitted to trading on AIM. Admission and trading in the new Ordinary Shares on AIM is expected to commence on or around 18 July 2016.

 

Director

No of warrants exercised

No of shares issued to facilitate the purchase of the Deferred Shares

No of Ordinary Shares held post exercise

No of Ordinary Shares held as a % of enlarged issued ordinary share capital

Neil Herbert

24,674,571

-

382,682,475

7.36

Barbara Spurrier*

5,747,618

3,721

11,514,457

0.22

* included in the figures above are the exercise of 4,285,714 warrants by CFPro Limited, a company with which Barbara Spurrier is connected. The resultant shareholding of CFPro Limited is 8,571,428 shares.

 

 

Total voting rights

Following the issue of the new Ordinary Shares, the Company's issued share capital consists of 5,200,000,000 Ordinary Shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Enquiries:

Frontier Resources International Plc

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

Beaufort Securities Limited (Broker) 

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

 

A copy of this announcement is available from the Company's website www.friplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESFFFEEFMSEDW
Date   Source Headline
2nd Dec 20204:25 pmRNSChange of name to MyHealthChecked Plc
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSAcquisition of home-use genetic testing company
28th Sep 20207:00 amRNSHalf-year Report
22nd Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSCommercial update; Change of registered office
2nd Jul 20203:24 pmRNSResult of AGM
5th Jun 20207:01 amRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSNotice of Annual General Meeting
2nd Jun 20207:00 amRNSCommercial update
29th May 20207:00 amRNSFinal Results
4th May 20207:00 amRNSPartnership agreement with Abingdon Health
27th Apr 20208:16 amRNSDirector/PDMR Shareholding
24th Apr 202011:26 amRNSResult of GM & Completion of Fundraise
14th Apr 20209:27 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSManufacturing outsourcing agreements for myLotus®
8th Apr 20207:00 amRNSPlacing and Subscription to raise £1.9 million
29th Jan 20207:00 amRNSTrading Update
14th Nov 20197:00 amRNSBoard Appointments
13th Nov 20198:35 amRNSBoard changes - replacement
13th Nov 20197:00 amRNSBoard Changes
31st Oct 20197:00 amRNSConcepta announces first myLotus® UK birth
25th Oct 20197:00 amRNSBoard Changes
30th Sep 20197:00 amRNSFirst myLotus® UK Fertility Clinic collaboration
30th Sep 20197:00 amRNSInterim Results
29th Jul 20197:00 amRNSGrant of Options
9th Jul 20197:00 amRNSmyLotus® pregnancies in double figures
13th Jun 20192:01 pmRNSResult of AGM
21st May 20199:00 amRNSNotice of AGM
14th May 20197:01 amRNSAnnual Results
14th May 20197:00 amRNSConcepta announces first myLotus® pregnancies
30th Apr 20194:28 pmRNSHolding(s) in Company
30th Apr 20191:46 pmRNSTR-1: form for notification of major holdings
29th Apr 20191:20 pmRNSTR-1: notification of major holdings
26th Apr 201910:52 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSPlacing to raise £2.3m; Notice of General Meeting
29th Mar 20197:00 amRNSConcepta to supply myLotus® to Boots UK
12th Mar 20197:00 amRNSConcepta to supply myLotus® to Walgreens Boots
17th Dec 20187:00 amRNSmyLotus® successful UK launch
31st Oct 20187:00 amRNSmyLotus® launch at The Fertility Show, London
29th Oct 20187:00 amRNSmyLotus gains CE-mark regulatory approval
5th Oct 20182:42 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSGrant of Options
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:37 pmRNSPrice Monitoring Extension
27th Sep 20187:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.